FDA Inspection 1155778 — Rhode Island Blood Center A Divison Of New York Blood Center Inc
The FDA completed an inspection of Rhode Island Blood Center A Divison Of New York Blood Center Inc on Oct 27, 2021 in Middletown, CT. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 27, 2021
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Middletown, CT (United States)